doi: 10.1016/0277-5379(88)90229-5.
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours
Affiliations
- PMID: 3181257
- DOI: 10.1016/0277-5379(88)90229-5
Item in Clipboard
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours
Eur J Cancer Clin Oncol.
1988 Aug.
Abstract
The novel nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosoure a (TCNU) is active against a panel of three transplantable murine adenocarcinomas of the colon of varying growth characteristics and morphology (MAC system). It shows greater activity than previously tested nitrosoureas in this system and the routes of administration of TCNU do not significantly alter its anti-tumour activity. These data suggest that TCNU may be useful in the management of large bowel cancer as the MAC system has been previously shown to be a good model of human disease.
Similar articles
-
Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma.Anticancer Res. 1992 Nov-Dec;12(6B):2169-75. Anticancer Res. 1992. PMID: 1295464
-
In vitro and in vivo responses of a panel of murine colon tumours to TCNU: a positive correlation.Eur J Cancer Clin Oncol. 1988 Aug;24(8):1365-71. doi: 10.1016/0277-5379(88)90230-1. Eur J Cancer Clin Oncol. 1988. PMID: 3181258
-
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations.Eur J Cancer Clin Oncol. 1988 Aug;24(8):1355-60. doi: 10.1016/0277-5379(88)90228-3. Eur J Cancer Clin Oncol. 1988. PMID: 3181256
-
TCNU: a ray of hope for designer nitrosoureas?Eur J Cancer Clin Oncol. 1987 Dec;23(12):1823-8. doi: 10.1016/0277-5379(87)90046-0. Eur J Cancer Clin Oncol. 1987. PMID: 3325292 Review. No abstract available.
-
Nitrosoureas: a review of experimental antitumor activity.Cancer Treat Rep. 1976 Jun;60(6):665-98. Cancer Treat Rep. 1976. PMID: 782694 Review.
Cited by
-
Pre-clinical evaluation of a novel chloroethylating agent, Clomesone.Br J Cancer. 1993 Mar;67(3):441-6. doi: 10.1038/bjc.1993.85. Br J Cancer. 1993. PMID: 8382507 Free PMC article.
-
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.Br J Cancer. 1992 Aug;66(2):323-30. doi: 10.1038/bjc.1992.264. Br J Cancer. 1992. PMID: 1503906 Free PMC article.
-
Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model.Invest New Drugs. 1992 Aug;10(3):149-58. doi: 10.1007/BF00877239. Invest New Drugs. 1992. PMID: 1428724
-
Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations.Pharmaceuticals (Basel). 2025 Jul 18;18(7):1056. doi: 10.3390/ph18071056. Pharmaceuticals (Basel). 2025. PMID: 40732343 Free PMC article.